Dataset from Interventional, Randomised, Double-blind, Parallel-group, Placebo-controlled, Flexible-dose Long-term Study to Evaluate the Maintenance of Efficacy and Safety of 1 to 3 mg/Day of Brexpiprazole as Adjunctive Treatment in Patients With Major Depressive Disorder With an Inadequate Response to Antidepressant Treatment
收藏NIAID Data Ecosystem2026-05-02 收录
下载链接：
https://doi.org/10.25934/PR00009116
下载链接
链接失效反馈官方服务：
资源简介：
To evaluate the long-term efficacy and safety of brexpiprazole as an adjunctive treatment to
an antidepressant treatment (ADT) for adult patients with Major Depressive Disorder (MDD).
创建时间：
2024-11-26
